{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:22:05Z","timestamp":1760908925304},"reference-count":22,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PED"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:sec>\n<jats:title>OBJECT<\/jats:title>\n<jats:p>Low-molecular-weight heparins (LMWHs), mainly enoxaparin, offer several advantages over standard anticoagulation therapies such as unfractionated heparin and warfarin, including predictable pharmacokinetics, minimal monitoring, and subcutaneous administration. The purpose of this study was to determine the safety and efficacy of LMWHs in pediatric neurosurgical patients.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>A retrospective study was performed with patients 18 years old or younger who were admitted to the Pediatric Neurosurgery Service at Texas Children's Hospital and treated with LMWH for either therapeutic or prophylactic purposes between March 1, 2011, and December 30, 2013. Demographic and clinical features and outcomes were recorded.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>LMWH was administered for treatment of venous thromboembolic events (VTEs) in 17 children and for prophylaxis in 24 children. Clinical resolution of VTEs occurred in 100% (17 of 17) of patients receiving therapeutic doses of LMWH. No patient receiving prophylactic doses of LMWH developed a new VTE. Major or minor bleeding complications occurred in 18% (3 of 17 children) and 4% (1 of 24 children) of those receiving therapeutic and prophylactic doses, respectively. All 4 patients who experienced hemorrhagic complications had other bleeding risk factors\u2014i.e., coagulopathies and antiplatelet medications.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>LMWH seems to be safe and efficacious for both management and prophylaxis of VTEs in pediatric neurosurgery. However, pediatric practitioners should be aware of higher risk for bleeding complications with increasing doses of LMWH, especially in patients with preexisting bleeding disorders or concurrent use of antiplatelet agents.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2015.1.peds14489","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T14:44:31Z","timestamp":1434120271000},"page":"329-334","source":"Crossref","is-referenced-by-count":12,"title":["The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients"],"prefix":"10.3171","volume":"16","author":[{"given":"David D.","family":"Gonda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Fridley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila L.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Brice\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandi K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MD","family":"MBA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Luerssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Jea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-peds14489","series-title":"Blood Coagul Fibrinolysis","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MBC.0b013e32835b72b8","article-title":"Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital","volume":"24","author":"Andrade-Campos","year":"2013"},{"key":"b2-peds14489","series-title":"Blood","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994"},{"key":"b3-peds14489","series-title":"J Pediatr","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0022-3476(98)70343-9","article-title":"Guidelines for antithrombotic therapy in pediatric patients","volume":"132","author":"Andrew","year":"1998"},{"key":"b4-peds14489","series-title":"J Pediatr Surg","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jpedsurg.2012.01.060","article-title":"Increased use of enoxaparin in pediatric trauma patients","volume":"47","author":"Askegard-Giesmann","year":"2012"},{"key":"b5-peds14489","series-title":"Am J Pediatr Hematol Oncol","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00043426-197923000-00007","article-title":"Neonatal thrombosis","volume":"1","author":"Barnard","year":"1979"},{"key":"b6-peds14489","series-title":"Pediatr Res","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1203\/00006450-197912000-00006","article-title":"Coagulation studies in extremely premature infants","volume":"13","author":"Barnard","year":"1979"},{"key":"b7-peds14489","series-title":"Neurol Rev","first-page":"36","article-title":"From major findings, a clearer picture of childhood stroke","volume":"6","author":"Bosworth","year":"1998"},{"key":"b8-peds14489","series-title":"Pediatr Crit Care Med","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/PCC.0b013e3181a705d3","article-title":"Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients","volume":"10","author":"Candrilli","year":"2009"},{"key":"b9-peds14489","series-title":"Can J Neurol Sci","first-page":"S21","article-title":"Canadian pediatric ischemic stroke registry (analysis III)","volume":"22","author":"deVeber","year":"1995"},{"key":"b10-peds14489","series-title":"J Pediatr","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0022-3476(00)90005-2","article-title":"The use of low molecular weight heparin in pediatric patients: a prospective cohort study","volume":"136","author":"Dix","year":"2000"},{"issue":"1 Suppl","key":"b11-peds14489","series-title":"J Neurosurg","first-page":"32","article-title":"Deep venous thrombosis in children and adolescents","volume":"101","author":"Levy","year":"2004"},{"key":"b12-peds14489","series-title":"J Pediatr Hematol Oncol","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00043426-200003000-00002","article-title":"Low-molecular-weight heparin therapy in children","volume":"22","author":"Massicotte","year":"2000"},{"key":"b13-peds14489","series-title":"J Pediatr Hematol Oncol","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00043426-200103000-00015","article-title":"Low-molecular-weight heparin therapy in children","volume":"23","author":"Massicotte","year":"2001"},{"key":"b14-peds14489","series-title":"J Pediatr","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0022-3476(96)70273-1","article-title":"Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study","volume":"128","author":"Massicotte","year":"1996"},{"key":"b15-peds14489","series-title":"Arch Dis Child Fetal Neonatal Ed","doi-asserted-by":"publisher","first-page":"F163","DOI":"10.1136\/fn.76.3.F163","article-title":"Neonatal symptomatic thromboembolism in Germany: two year survey","volume":"76","author":"Nowak-G\u00f6ttl","year":"1997"},{"key":"b16-peds14489","series-title":"J Pediatr Surg","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0022-3468(81)80858-5","article-title":"Management of major thromboembolic complications of umbilical artery catheters","volume":"16","author":"O\u2019Neill","year":"1981"},{"key":"b17-peds14489","series-title":"J Pediatr Hematol Oncol","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00043426-200003000-00011","article-title":"Low-molecular-weight heparin in thrombotic disease in children and adolescents","volume":"22","author":"Punzalan","year":"2000"},{"key":"b18-peds14489","series-title":"Pediatrics","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1542\/peds.96.5.939","article-title":"Neonatal thrombosis: report of a prospective Canadian and international registry","volume":"96","author":"Schmidt","year":"1995"},{"key":"b19-peds14489","series-title":"J Pediatr","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0022-3476(88)80293-2","article-title":"Neonatal thrombotic disease: prevention, diagnosis, and treatment","volume":"113","author":"Schmidt","year":"1988"},{"key":"b20-peds14489","series-title":"Clin Perinatol","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0095-5108(18)30929-1","article-title":"Thrombotic disease in newborn infants","volume":"11","author":"Schmidt","year":"1984"},{"key":"b21-peds14489","series-title":"J Pediatr Surg","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.jpedsurg.2013.02.059","article-title":"Venous thromboembolism prophylaxis in the pediatric trauma population","volume":"48","author":"Thompson","year":"2013"},{"key":"b22-peds14489","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997"}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/16\/3\/article-p329.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/16\/3\/article-p329.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/16\/3\/article-p329.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T11:58:52Z","timestamp":1681559932000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/16\/3\/article-p329.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":22,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2015.1.peds14489","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}